Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genetic Technologies Ltd (NASDAQ:GENE)

1.09
Delayed Data
As of May 26
 0.00 / 0.00%
Today’s Change
1.04
Today|||52-Week Range
2.89
+0.93%
Year-to-Date
Institutional investors purchased a net $630.6 thousand shares of GENE during the quarter ended December 2016, and now own 13.03% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Other institutional13.03%
Mutual fund holders0.00%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

3/31/2017RENAISSANCE TECHNOLOGIES LLC  Bought 158.3 Thousand shares of Genetic Technologies Ltd
3/31/2017BNY MELLON CAPITAL MARKETS LLC  Bought 34.7 Thousand shares of Genetic Technologies Ltd
3/31/2017CITADEL ADVISORS LLC  Bought 11.1 Thousand shares of Genetic Technologies Ltd

Top 10 Owners of Genetic Technologies Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Renaissance Technologies LLC5.16%837,3801,021,604+158,300+23.31%
Heights Capital Management, Inc.3.94%639,403780,072-283,955-30.75%
Sabby Capital LLC3.51%570,073695,489-500,260-46.74%
BNY Mellon Capital Markets LLC0.21%34,72742,367+34,727--
Citadel Advisors LLC0.07%11,06913,504+11,069--
UBS Securities LLC0.04%7,1658,741+7,165--
Cutler Group LP0.03%4,8005,85600.00%
Simplex Trading LLC0.03%4,3125,261+3,356+351.05%
KMS Financial Services, Inc.0.02%2,7503,35500.00%
Morgan Stanley Smith Barney LLC (...0.01%1,5001,83000.00%

Top 10 Mutual Funds Holding Genetic Technologies Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Trust for Professional Managers -...0.00%00-5,546-100.00%